Vanessa Pataia,  —

Underweight CF Patients Have Lung Transplant Survival Rates Comparable to Recipients With Other Lung Conditions, Study Reports

Cystic fibrosis (CF) patients with low body weight are not at increased risk of mortality after a lung transplant, compared to people with other lung diseases who require the transplant, a new study reports. The findings were described in the study “Underweight patients with cystic fibrosis…

Crestone Awarded Funding by Cystic Fibrosis Foundation to Develop Antibiotic That Fights NTM Infections

Crestone has received an award from the Cystic Fibrosis Foundation (CFF) to develop preclinical studies for an antibiotic to treat non-tuberculous mycobacteria (NTM) infections. NTMs are responsible for lung infections in 14% of people with cystic fibrosis (CF). The number of people affected by lung NTM infections is steadily…

Two Pivotal Phase 3 Trials of Proteostasis’ CF Triple Combo Therapy to Open in 2020

Proteostasis Therapeutics announced plans to open two Phase 3 clinical trials of its triple combination therapy candidate for cystic fibrosis this year, after a meeting with the chief healthcare regulatory office for the U.K. One of these pivotal trials will be investigating the possibility of organoids being used for personalized…

Antabio Awarded $4.4M for Continued Research for P. aeruginosa Lung Infection Therapy

Biopharmaceutical company Antabio has been awarded $4.4 million by CARB-X to continue its research for a therapy against Pseudomonas aeruginosa lung infections in people with cystic fibrosis (CF). The funding will be used to support Antabio’s Pseudomonas Elastase Inhibitor (PEi) program, which is seeking to develop…